Transthyretin
Links shared publicly online about this topic
Abstract | A possible role for miRNA silencing in disease phenotype variation in Swedish transthyretin V30M carriers
biomedcentral.com — “Abstract | A possible role for miRNA silencing in disease phenotype variation in Swedish transthyretin V30M carriers” View full resource at biomedcentral.com
Most Recently Shared on September 14, 2010 at 1:47 pm By:
A possible role for miRNA silencing in disease phenotype variation in Swedish transthyretin V30M carriers: Conclus... http://bit.ly/bM4Tjy
NDA Accepted for Tafamidis Meglumine for Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP) - MPR
empr.com — “Pfizer Inc. announced that the FDA has accepted its New Drug Application (NDA) for tafamidis meglumine for the treatment of Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP).” View full resource at empr.com
Most Recently Shared on February 15, 2012 at 3:55 pm By:
NDA Accepted for Tafamidis Meglumine for Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP) http://t.co/hltLvmxI #neurodegenerative
Pfizer receives FDA Refusal to File letter for tafamidis to treat Transthyretin Familial Amyloid Polyneuropathy
news-medical.net — “Pfizer Inc. announced today that it has received a Refusal to File letter from the United States Food and Drug Administration (FDA) for tafamidis, the company's novel, oral investigational compound for patients with Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP).” View full resource at news-medical.net
Most Recently Shared on April 4, 2011 at 3:03 pm By:
Pfizer receives FDA Refusal to File letter for tafamidis to treat Transthyretin Familial Amyloid Polyneuropathy:... http://bit.ly/hqTsvh
Alnylam Pharmaceuticals presents new data from its transthyretin-mediated amyloidosis program
news-medical.net — “Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it presented new pre-clinical research findings from its transthyretin (TTR)-mediated amyloidosis (ATTR) program at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (The Liver Meeting).” View full resource at news-medical.net
Most Recently Shared on November 2, 2009 at 11:15 pm By:
News-Medical.Net Health News and Oncology
Oncology News: Alnylam Pharmaceuticals presents new data from its transthyretin-mediated amyloido.. http://bit.ly/2KcN3g
Tafamidis, An Oral, Investigational Compound For The Treatment Of Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP) Sustained A Slowing Of Disease Progression Over 30 Months - Drugs.com MedNews
drugs.com — “Data Presented in an Oral Session at the 63rd Annual Meeting of the American Academy of Neurology Apr 12, 2011 - Pfizer Inc. (NYSE PFE) announced today data fro” View full resource at drugs.com
Most Recently Shared on April 13, 2011 at 12:05 pm By:
Drugs and Devices OW OW Health
Tafamidis, An Oral, Investigational Compound For The Treatment Of Transthyretin Familial Amyloid Polyneuro... http://bit.ly/fCUjLM #drug
Thyroxine-Binding Globulin Deficiency: eMedicine Endocrinology
emedicine.medscape.com — “Overview: The thyroid hormones (THs)-thyroxine (T4) and 3,5,3'-triiodothyronine (T3)-circulate in blood by reversibly binding to carrier proteins. Although only 0.3% or less of ...” View full resource at emedicine.medscape.com
Most Recently Shared on May 10, 2010 at 5:47 pm By:
Thyroxine-binding globulin deficiency can be caused by both inherited or acquired means. Learn more about causes. http://bit.ly/cF5lbi
Wireless Phones Alter Levels of Brain Chemical
health.msn.com — “Wireless Phones Alter Levels of Brain Chemical” View full resource at health.msn.com
Most Recently Shared on November 12, 2009 at 9:50 pm By:
Wireless Phones Alter Levels of Brain Chemical http://bit.ly/JZtgV
Alnylam And Collaborators Present Data From Multiple Pre-Clinical And Clinical Programs At RNAi Keystone Symposium
medicalnewstoday.com — “Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it presented data from multiple pre-clinical and clinical programs at the RNA Silencing: Me” View full resource at medicalnewstoday.com
Most Recently Shared on January 21, 2010 at 7:37 am By:
Alnylam And Collaborators Present Data From Multiple Pre-Clinical And Clinical Programs At RNAi Keystone Symposium Al.. http://bit.ly/53CxYb
Neurology Article | Amyloidosis
mdlinx.com — “Systemic but asymptomatic transthyretin amyloidosis 8 years after domino liver transplantation” View full resource at mdlinx.com
Most Recently Shared on November 14, 2010 at 1:32 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Systemic but asymptomatic transthyretin amyloidosis 8 years after domino liver transplantation: Journal o... http://bit.ly/cFxIHb #neuro
Oncology Article - Pancreatic Neoplasms
mdlinx.com — “Transthyretin, identified by proteomics, is overabundant in pancreatic juice from pancreatic carcinoma and originates from pancreatic islets” View full resource at mdlinx.com
Most Recently Shared on November 1, 2010 at 2:08 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Transthyretin, identified by proteomics, is overabundant in pancreatic juice from pancreatic carcinoma an... http://bit.ly/ahD2yv #oncology
Wireless Phones Alter Levels of Brain Chemical - myOptumHealth
myoptumhealth.com — “Read the news article Wireless Phones Alter Levels of Brain Chemical at www.myOptumHealth.com” View full resource at myoptumhealth.com
Most Recently Shared on November 13, 2009 at 12:09 am By:
Wireless Phones Alter Levels of Brain Chemical: Study found elevated amounts of protein involved in blood-brain barrier http://bit.ly/2kFZFh
Pfizer Receives Refusal To File Letter From U.S. FDA On Tafamidis New Drug Application
drugs.com — “Tafamidis is a new drug in development for the treatment of Transthyretin Familial Amyloid Polyneuropathy. Tafamidis information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on April 19, 2011 at 4:15 am By:
Drugs and Devices OW OW Health
Pfizer Receives Refusal To File Letter From U.S. FDA On Tafamidis New Drug Application: NEW YORK--(BUSINES... http://bit.ly/g2M9hN #drug
Scientists find new drug candidates for set of protein-folding diseases
medicalxpress.com — “Collaborating researchers at Stanford University and The Scripps Research Institute have identified chemical compounds that show promise as potential therapeutics for a set of medical conditions caused by the abnormal clumping together of a protein known as transthyretin (TTR).” View full resource at medicalxpress.com
Most Recently Shared on August 29, 2011 at 6:45 pm By:
PhysOrg Health News Health News
Scientists find new drug candidates for set of protein-folding diseases http://t.co/Cp45gkt
Isis Initiates Phase 1 Study of ISIS-TTRRx and Earns $5 Million Milestone... -- CARLSBAD, Calif., May 19, 2011 /PRNewswire/ --
prnewswire.com — “Isis Initiates Phase 1 Study of ISIS-TTRRx and Earns $5 Million Milestone Payment From GlaxoSmithKline.” View full resource at prnewswire.com
Most Recently Shared on May 19, 2011 at 11:54 am By:
Lisa Jarvis Science Enthusiast
$ISIS gets $5m payment from $GSK as Phase I study for ISIS-TTRRx (for rare disease transthyretin amyloidosis) begins: http://prn.to/jGrSdL
Cell Phone Use Linked to Brain Changes | LiveScience
livescience.com — “Study finds an association between cell phone use and an increased amount of a protein called transthyretin in the bloo” View full resource at livescience.com
Most Recently Shared on November 17, 2009 at 1:28 pm By:
Dr. John Dempster Active Health Library, Acupuncturist, CAM, and Naturopathic Doctor
Cell Phone Use Linked to Brain Changes http://www.livescience.com/technology/091112-cell-phone-brain.html
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Genetics OW
Organizing genetics resources shared by health experts, advocates, and organizations into WisdomCards.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
News-Medical.Net
Medical News from Around the World
Advertisement
